The cells in the granulocytic series that give rise to mature granulocytes (NEUTROPHILS; EOSINOPHILS; and BASOPHILS). These precursor cells include myeloblasts, promyelocytes, myelocytes and metamyelocytes.
Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS.
The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines.
Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification, such as cleavage, to produce the active functional protein or peptide hormone.
Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.
Progenitor cells from which all blood cells derive.
Receptors that bind and internalize GRANULOCYTE COLONY-STIMULATING FACTOR. Their MW is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
A class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system.
The external genitalia of the female. It includes the CLITORIS, the labia, the vestibule, and its glands.
Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.
The developmental history of specific differentiated cell types as traced back to the original STEM CELLS in the embryo.
An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages.
A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.

G-CSF signaling can differentiate promyelocytes expressing a defective retinoic acid receptor: evidence for divergent pathways regulating neutrophil differentiation. (1/124)

Several lines of investigation suggest that granulocyte colony-stimulating factor (G-CSF) augments all-trans retinoic acid (ATRA)-induced neutrophil differentiation in acute promyelocytic leukemia (APL). We sought to characterize the relationship between G-CSF- and ATRA-mediated neutrophil differentiation. We established a G-CSF receptor-transduced promyelocytic cell line, EPRO-Gr, derived from the granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent EPRO cell line harboring a dominant-negative retinoic acid receptor alpha (RARalpha). In EPRO-Gr, neutrophil differentiation occurs either in GM-CSF upon addition of ATRA or upon induction with G-CSF alone. Transient transfection of EPRO-Gr cells with a RARE-containing reporter plasmid demonstrates increased activity in the presence of ATRA, but not G-CSF, while STAT3 phosphorylation occurs only in response to G-CSF. This suggests that ATRA-mediated differentiation of EPRO-Gr cells occurs via a RARE-dependent, STAT3-independent pathway, while G-CSF-mediated differentiation occurs via a RARE-independent, STAT3-dependent pathway. ATRA and G-CSF thus regulate differentiation by divergent pathways. We characterized these pathways in the APL cell line, NB4. ATRA induction of NB4 cells resulted in morphologic differentiation and up-regulation of C/EBPepsilon and G-CSFR, but not in STAT3 phosphorylation. The addition of G-CSF with ATRA during NB4 induction resulted in STAT3 phosphorylation but did not enhance differentiation. These results may elucidate how G-CSF and ATRA affect the differentiation of primary and ATRA-resistant APL cells.  (+info)

CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. (2/124)

The HOXA9 homeodomain protein is a key regulator of hematopoiesis and embryonic development. HOXA9 is expressed in primitive hematopoietic cells, and its prompt downregulation is associated with myelocytic maturation. Although transcriptional inactivation of HOXA9 during hematopoietic differentiation has been established, little is known about the biochemical mechanisms underlying the subsequent removal of HOXA9 protein. Here we report that the CUL-4A ubiquitylation machinery controls the stability of HOXA9 by promoting its ubiquitylation and proteasome-dependent degradation. The homeodomain of HOXA9 is responsible for CUL-4A-mediated degradation. Interfering CUL-4A biosynthesis by ectopic expression or by RNA-mediated interference resulted in alterations of the steady-state levels of HOXA9, mirrored by impairment of the ability of 32D myeloid progenitor cells to undergo proper terminal differentiation into granulocytes. These results revealed a novel regulatory mechanism of hematopoiesis by ubiquitin-dependent proteolysis.  (+info)

Alpha-defensin expression during myelopoiesis: identification of cis and trans elements that regulate expression of NP-3 in rat promyelocytes. (3/124)

Alpha-defensins are antimicrobial peptides that contribute to innate-immune functions of neutrophils and intestinal Paneth cells. Transcription of alpha-defensin genes occurs early in neutrophilic myelopoeisis. To examine the mechanisms that regulate alpha-defensin gene expression, we analyzed transcription of rat neutrophil alpha-defensin NP-3 in D4 cells, a subclone of the promyelocytic cell line IPC-81. Northern blot analysis showed that D4 cells express fivefold higher levels of alpha-defensin mRNA than the parental cell line in a manner relatively independent of passage number. Increased levels of steady-state mRNA in D4 cells correlated with markedly elevated peptide levels detected by immunocytochemical staining. To identify the cis-acting DNA elements involved in tissue-specific expression, D4 cells were transfected with luciferase reporter constructs containing NP-3 gene 5'-flanking sequences. Analyses of transfected D4 cells demonstrated that the proximal 87 base pair (bp) sequence contained cis-acting DNA elements necessary for optimal promoter activity. Mutational analyses within the 87-bp region suggested the involvement of the CAAT box and a putative polyoma enhancer-binding protein 2/core-binding factor (PEBP2/CBF) site in defensin gene transcription. Transient transfection analyses using tandem repeats of oligonucleotides containing these sequences demonstrated that proximity of the CAAT box and PEBP2/CBF site was important for defensin promoter activity. Electrophoretic mobility shift assays indicated that PEBP2/CBF or a PEBP2/CBF-related protein was involved in a specific protein-DNA interaction occurring within a DNA fragment containing the CAAT and PEBP2/CBF sequences. These data identify functional trans- and cis-elements that regulate rat defensin gene expression in high defensin-expressing promyelocytic cells.  (+info)

Influence of dosing schedule on toxicity and antitumor effects of a combination of adriamycin and docetaxel in mice. (4/124)

PURPOSE: Although the combination of Adriamycin (ADR) and docetaxel (DOC) showed a better cure rate against metastatic breast cancer in a clinical study, severe myelosuppression and cardiotoxicity were dose-limiting factors. The purpose of this study was to establish the most suitable dosing schedule to relieve severe adverse effects and improve the antitumor effects. EXPERIMENTAL DESIGN: Both ADR and DOC were administered simultaneously in the simultaneous-dosing group (ADR/DOC), whereas in the intermittent-dosing groups (ADR-DOC and DOC-ADR), the second drug was administered 12 h after the first drug. Leukocyte counts and survival were measured to estimate adverse effects. After administration, ADR and DOC concentrations in blood, myelocyte cells, and heart were determined. To clarify the antitumor effect, tumor growth was measured in Ehrlich-cell-bearing mice after the initiation of drug injections. RESULTS: The simultaneous-dosing group showed severe leukopenia compared with the saline-treated group. However, the toxicity was reduced in the intermittent-dosing groups. The DOC-ADR group showed the best survival rate in the dosing groups. In the pharmacokinetic study, ADR and DOC concentrations in plasma, myelocyte cells, and the heart were markedly higher in the simultaneous-dosing group than the intermittent-dosing groups. These results indicate that pharmacokinetic interactions may contribute to the change in leukopenia induced by concurrent administration of ADR and DOC. The antitumor effect in the DOC-ADR group was the highest in the dosing groups. CONCLUSIONS: In the present study, the findings suggest that ADR administered 12 h after DOC injection (DOC-ADR group) not only inhibits tumor growth more strongly but also significantly reduces leukopenia compared with results for the simultaneous-dosing (ADR/DOC) group and significantly reduced the number of toxic deaths compared with the other groups.  (+info)

c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia. (5/124)

BACKGROUND: The c-Kit receptor is considered to play a crucial role in hematopoiesis. Induction of mobilization of hematopoietic cells in the bone marrow requires cooperative signaling through c-Kit and c-Kit ligand pathway, and these interactions are important in the retention of stem cells within the bone marrow. Therefore, we analyzed c-Kit density on the leukemic myeloblasts of patients with acute myeloid leukemia (AML) in relation to white blood cell count (WBC) in the peripheral blood. METHODS: Bone marrow aspirates collected from patients with AML and bone marrow aspirates and leukapheresis products after granulocyte colony-stimulating factor blood mobilization from adult volunteers were studied. To determine the level of c-Kit receptor expression, we applied quantitative (relative fluorescence intensity and antibody binding per cell) cytometric methods. RESULTS: Our data showed negative correlation between the level of c-Kit expression intensity on myeloblasts and the number of leukocytes in blood of AML patients. The c-Kit receptor density on myeloblasts in patients with low WBC was significantly stronger than that on myeloblasts in patients with high WBC. In the latter patient group, the density c-Kit receptor on myeloblasts was similar to that on CD34(+) cells in mobilized peripheral blood. CONCLUSIONS: The obtained data suggest an involvement of c-Kit receptor in the regulation of leukemic myeloblasts egress to the peripheral blood.  (+info)

Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature. (6/124)

The involvement of central nervous system is rare in acute promyelocytic leukemia (APL). We report a APL patient of a 41 yr-old Korean male who presented with fever and petechia. Complete molecular remission was achieved with all-trans retinoic acid (ATRA), idarubicin, and cytarabine. Ten months later, he complained of a mild headache. The results of the physical examination and the complete blood counts were normal. The examination of cerebrospinal fluid showed the presence of promyelocyte. Bone marrow studies showed cytogenetic remission but with molecular relapse. He was treated with intrathecal and systemic chemotherapy.  (+info)

Interference of BCR-ABL1 kinase activity with antigen receptor signaling in B cell precursor leukemia cells. (7/124)

The chromosomal translocation t,(9;22) resulting in the fusion of the BCR and ABL1 genes, represents a recurrent aberration in B cell precursor leukemia cells. Their normal counterparts, B cell precursor cells, are positively selected for survival signals through the antigen receptor, whose expression requires a functional immunoglobulin heavy chain (IGH) gene rearrangement. Unexpectedly, B cell precursor leukemia cells harboring a BCR-ABL1 gene rearrangement do not depend on antigen receptor mediated survival signals. Genes involved in the signaling cascade of the antigen receptor are silenced and in most cases, the dominant tumor clone does not carry a functional IGH gene rearrangement. However, upon inhibition of the BCR-ABL1 kinase activity by STI571, only leukemia cells expressing an antigen receptor are able to survive. Since resistance to STI571 is frequent in the therapy of BCR-ABL1(+) B cell precursor leukemia, antigen receptor signaling may represent a mechanism through which these cells can temporarily evade STI571-induced apoptosis. This may open a time frame, during which leukemia cells acquire secondary transforming events that confer definitive resistance to STI571.  (+info)

Phospholipases D1 and D2 coordinately regulate macrophage phagocytosis. (8/124)

Phagocytosis is a fundamental feature of the innate immune system, required for antimicrobial defense, resolution of inflammation, and tissue remodeling. Furthermore, phagocytosis is coupled to a diverse range of cytotoxic effector mechanisms, including the respiratory burst, secretion of inflammatory mediators and Ag presentation. Phospholipase D (PLD) has been linked to the regulation of phagocytosis and subsequent effector responses, but the identity of the PLD isoform(s) involved and the molecular mechanisms of activation are unknown. We used primary human macrophages and human THP-1 promonocytes to characterize the role of PLD in phagocytosis. Macrophages, THP-1 cells, and other human myelomonocytic cells expressed both PLD1 and PLD2 proteins. Phagocytosis of complement-opsonized zymosan was associated with stimulation of the activity of both PLD1 and PLD2, as demonstrated by a novel immunoprecipitation-in vitro PLD assay. Transfection of dominant-negative PLD1 or PLD2 each inhibited the extent of phagocytosis (by 55-65%), and their combined effects were additive (reduction of 91%). PLD1 and PLD2 exhibited distinct localizations in resting macrophages and those undergoing phagocytosis, and only PLD1 localized to the phagosome membrane. The COS-7 monkey fibroblast cell line, which has been used as a heterologous system for the analysis of receptor-mediated phagocytosis, expressed PLD2 but not PLD1. These data support a model in which macrophage phagocytosis is coordinately regulated by both PLD1 and PLD2, with isoform-specific localization. Human myelomonocytic cell lines accurately model PLD-dependent signal transduction events required for phagocytosis, but the heterologous COS cell system does not.  (+info)

Granulocyte precursor cells, also known as myeloid precursors or myeloblasts, are early-stage cells found in the bone marrow. These cells are part of the production process for granulocytes, a type of white blood cell that plays a crucial role in fighting off infections.

Granulocyte precursor cells differentiate and mature into three main types of granulocytes: neutrophils, eosinophils, and basophils. These cells have distinct functions in the immune response, such as neutralizing and destroying invading pathogens (neutrophils), regulating inflammation and fighting parasitic infections (eosinophils), and mediating allergic reactions and inflammation (basophils).

Abnormalities in granulocyte precursor cells can lead to various medical conditions, such as leukemia, where these cells become cancerous and multiply uncontrollably. Monitoring granulocyte precursor cells is essential for diagnosing and managing hematological disorders.

Granulocytes are a type of white blood cell that plays a crucial role in the body's immune system. They are called granulocytes because they contain small granules in their cytoplasm, which are filled with various enzymes and proteins that help them fight off infections and destroy foreign substances.

There are three types of granulocytes: neutrophils, eosinophils, and basophils. Neutrophils are the most abundant type and are primarily responsible for fighting bacterial infections. Eosinophils play a role in defending against parasitic infections and regulating immune responses. Basophils are involved in inflammatory reactions and allergic responses.

Granulocytes are produced in the bone marrow and released into the bloodstream, where they circulate and patrol for any signs of infection or foreign substances. When they encounter a threat, they quickly move to the site of infection or injury and release their granules to destroy the invading organisms or substances.

Abnormal levels of granulocytes in the blood can indicate an underlying medical condition, such as an infection, inflammation, or a bone marrow disorder.

Bone marrow is the spongy tissue found inside certain bones in the body, such as the hips, thighs, and vertebrae. It is responsible for producing blood-forming cells, including red blood cells, white blood cells, and platelets. There are two types of bone marrow: red marrow, which is involved in blood cell production, and yellow marrow, which contains fatty tissue.

Red bone marrow contains hematopoietic stem cells, which can differentiate into various types of blood cells. These stem cells continuously divide and mature to produce new blood cells that are released into the circulation. Red blood cells carry oxygen throughout the body, white blood cells help fight infections, and platelets play a crucial role in blood clotting.

Bone marrow also serves as a site for immune cell development and maturation. It contains various types of immune cells, such as lymphocytes, macrophages, and dendritic cells, which help protect the body against infections and diseases.

Abnormalities in bone marrow function can lead to several medical conditions, including anemia, leukopenia, thrombocytopenia, and various types of cancer, such as leukemia and multiple myeloma. Bone marrow aspiration and biopsy are common diagnostic procedures used to evaluate bone marrow health and function.

Granulocyte Colony-Stimulating Factor (G-CSF) is a type of growth factor that specifically stimulates the production and survival of granulocytes, a type of white blood cell crucial for fighting off infections. G-CSF works by promoting the proliferation and differentiation of hematopoietic stem cells into mature granulocytes, primarily neutrophils, in the bone marrow.

Recombinant forms of G-CSF are used clinically as a medication to boost white blood cell production in patients undergoing chemotherapy or radiation therapy for cancer, those with congenital neutropenia, and those who have had a bone marrow transplant. By increasing the number of circulating neutrophils, G-CSF helps reduce the risk of severe infections during periods of intense immune suppression.

Examples of recombinant G-CSF medications include filgrastim (Neupogen), pegfilgrastim (Neulasta), and lipegfilgrastim (Lonquex).

Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification to become active. These modifications typically include cleavage of the precursor protein by specific enzymes, resulting in the release of the active protein. This process allows for the regulation and control of protein activity within the body. Protein precursors can be found in various biological processes, including the endocrine system where they serve as inactive hormones that can be converted into their active forms when needed.

Cell differentiation is the process by which a less specialized cell, or stem cell, becomes a more specialized cell type with specific functions and structures. This process involves changes in gene expression, which are regulated by various intracellular signaling pathways and transcription factors. Differentiation results in the development of distinct cell types that make up tissues and organs in multicellular organisms. It is a crucial aspect of embryonic development, tissue repair, and maintenance of homeostasis in the body.

According to the National Institutes of Health (NIH), stem cells are "initial cells" or "precursor cells" that have the ability to differentiate into many different cell types in the body. They can also divide without limit to replenish other cells for as long as the person or animal is still alive.

There are two main types of stem cells: embryonic stem cells, which come from human embryos, and adult stem cells, which are found in various tissues throughout the body. Embryonic stem cells have the ability to differentiate into all cell types in the body, while adult stem cells have more limited differentiation potential.

Stem cells play an essential role in the development and repair of various tissues and organs in the body. They are currently being studied for their potential use in the treatment of a wide range of diseases and conditions, including cancer, diabetes, heart disease, and neurological disorders. However, more research is needed to fully understand the properties and capabilities of these cells before they can be used safely and effectively in clinical settings.

Hematopoietic stem cells (HSCs) are immature, self-renewing cells that give rise to all the mature blood and immune cells in the body. They are capable of both producing more hematopoietic stem cells (self-renewal) and differentiating into early progenitor cells that eventually develop into red blood cells, white blood cells, and platelets. HSCs are found in the bone marrow, umbilical cord blood, and peripheral blood. They have the ability to repair damaged tissues and offer significant therapeutic potential for treating various diseases, including hematological disorders, genetic diseases, and cancer.

Granulocyte colony-stimulating factor (G-CSF) receptors are specialized protein structures found on the surface of certain types of white blood cells, specifically neutrophils, as well as their precursor cells in the bone marrow. These receptors play a crucial role in regulating the production, differentiation, and function of these important immune cells.

G-CSF is a hormone-like growth factor that is produced by various cells in the body, including monocytes, fibroblasts, and endothelial cells. When G-CSF binds to its receptor on the surface of a neutrophil or precursor cell, it activates a series of intracellular signaling pathways that promote the proliferation and differentiation of these cells. This leads to an increase in the number of mature neutrophils available to fight infection and help maintain immune surveillance.

G-CSF receptors are members of the cytokine receptor superfamily, which includes a variety of receptors that bind to different types of growth factors and hormones. The G-CSF receptor is composed of two subunits, an alpha subunit that binds to G-CSF and a beta subunit that is shared with other cytokine receptors. When G-CSF binds to the alpha subunit, it induces a conformational change that allows the beta subunit to activate intracellular signaling pathways, including the JAK/STAT and MAPK pathways.

In addition to their role in regulating neutrophil production and function, G-CSF receptors have also been implicated in a variety of other physiological processes, including hematopoiesis, inflammation, and tissue repair. Dysregulation of the G-CSF signaling pathway has been associated with various diseases, including cancer, autoimmune disorders, and bone marrow failure syndromes.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Oligodendroglia are a type of neuroglial cell found in the central nervous system (CNS) of vertebrates, including humans. These cells play a crucial role in providing support and insulation to nerve fibers (axons) in the CNS, which includes the brain and spinal cord.

More specifically, oligodendroglia produce a fatty substance called myelin that wraps around axons, forming myelin sheaths. This myelination process helps to increase the speed of electrical impulse transmission (nerve impulses) along the axons, allowing for efficient communication between different neurons.

In addition to their role in myelination, oligodendroglia also contribute to the overall health and maintenance of the CNS by providing essential nutrients and supporting factors to neurons. Dysfunction or damage to oligodendroglia has been implicated in various neurological disorders, such as multiple sclerosis (MS), where demyelination of axons leads to impaired nerve function and neurodegeneration.

The vulva refers to the external female genital area. It includes the mons pubis (the pad of fatty tissue covered with skin and hair that's located on the front part of the pelvis), labia majora (the outer folds of skin that surround and protect the vaginal opening), labia minora (the inner folds of skin that surround the vaginal and urethral openings), clitoris (a small, sensitive organ located at the front of the vulva where the labia minora join), the external openings of the urethra (the tube that carries urine from the bladder out of the body) and vagina (the passageway leading to the cervix, which is the lower part of the uterus).

It's important to note that understanding the anatomy and terminology related to one's own body can help facilitate effective communication with healthcare providers, promote self-awareness, and support overall health and well-being.

Bone marrow cells are the types of cells found within the bone marrow, which is the spongy tissue inside certain bones in the body. The main function of bone marrow is to produce blood cells. There are two types of bone marrow: red and yellow. Red bone marrow is where most blood cell production takes place, while yellow bone marrow serves as a fat storage site.

The three main types of bone marrow cells are:

1. Hematopoietic stem cells (HSCs): These are immature cells that can differentiate into any type of blood cell, including red blood cells, white blood cells, and platelets. They have the ability to self-renew, meaning they can divide and create more hematopoietic stem cells.
2. Red blood cell progenitors: These are immature cells that will develop into mature red blood cells, also known as erythrocytes. Red blood cells carry oxygen from the lungs to the body's tissues and carbon dioxide back to the lungs.
3. Myeloid and lymphoid white blood cell progenitors: These are immature cells that will develop into various types of white blood cells, which play a crucial role in the body's immune system by fighting infections and diseases. Myeloid progenitors give rise to granulocytes (neutrophils, eosinophils, and basophils), monocytes, and megakaryocytes (which eventually become platelets). Lymphoid progenitors differentiate into B cells, T cells, and natural killer (NK) cells.

Bone marrow cells are essential for maintaining a healthy blood cell count and immune system function. Abnormalities in bone marrow cells can lead to various medical conditions, such as anemia, leukopenia, leukocytosis, thrombocytopenia, or thrombocytosis, depending on the specific type of blood cell affected. Additionally, bone marrow cells are often used in transplantation procedures to treat patients with certain types of cancer, such as leukemia and lymphoma, or other hematologic disorders.

'Cell lineage' is a term used in biology and medicine to describe the developmental history or relationship of a cell or group of cells to other cells, tracing back to the original progenitor or stem cell. It refers to the series of cell divisions and differentiation events that give rise to specific types of cells in an organism over time.

In simpler terms, cell lineage is like a family tree for cells, showing how they are related to each other through a chain of cell division and specialization events. This concept is important in understanding the development, growth, and maintenance of tissues and organs in living beings.

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) is a type of cytokine, which is a small signaling protein involved in immune response and hematopoiesis (the formation of blood cells). GM-CSF's specific role is to stimulate the production, proliferation, and activation of granulocytes (a type of white blood cell that fights against infection) and macrophages (large white blood cells that eat foreign substances, bacteria, and dead or dying cells).

In medical terms, GM-CSF is often used in therapeutic settings to boost the production of white blood cells in patients undergoing chemotherapy or radiation treatment for cancer. This can help to reduce the risk of infection during these treatments. It can also be used to promote the growth and differentiation of stem cells in bone marrow transplant procedures.

The Amyloid Beta-Protein Precursor (AβPP) is a type of transmembrane protein that is widely expressed in various tissues and organs, including the brain. It plays a crucial role in normal physiological processes, such as neuronal development, synaptic plasticity, and repair.

AβPP undergoes proteolytic processing by enzymes called secretases, resulting in the production of several protein fragments, including the amyloid-beta (Aβ) peptide. Aβ is a small peptide that can aggregate and form insoluble fibrils, which are the main component of amyloid plaques found in the brains of patients with Alzheimer's disease (AD).

The accumulation of Aβ plaques is believed to contribute to the neurodegeneration and cognitive decline observed in AD. Therefore, AβPP and its proteolytic processing have been the focus of extensive research aimed at understanding the pathogenesis of AD and developing potential therapies.

Chloromas are composed of granulocyte precursor cells. These are rare solid extramedullary tumors that usually have a mass ... On nonenhanced scans, some metastases of vascular primary tumors, such as renal cell carcinomas, pancreatic islet cell tumors, ... The detection of the Kupffer cells in FNH lesions has historically been the role of scanning with 99mTc sulfur colloid. In ... Because the Kupffer cells are unaffected by fatty infiltration, sulfur colloid scans are typically normal. Sulfur colloid ...
NME3 suppressed granulocyte differentiation and induced apoptosis of myeloid precursor cells. Model organisms have been used in ... Collins FS, Rossant J, Wurst W (Jan 2007). "A mouse for all reasons". Cell. 128 (1): 9-13. doi:10.1016/j.cell.2006.12.018. PMID ... Cell. 154 (2): 452-64. doi:10.1016/j.cell.2013.06.022. PMC 3717207. PMID 23870131. "Infection and Immunity Immunophenotyping ( ... Non-metastatic cells 4, protein expressed in, also known as NME4, is a protein which in humans is encoded by the NME4 gene. The ...
G-CSF and other growth factors have been demonstrated to stimulate leukemia cells as well as normal granulocyte precursors in ... In "A waiting trial," 1 which explores whether Doug Bermans participation in a clinical trial of cardiac stem cells triggered ... doctors jabbed a needle filled with either saline or Bergmans own CD34+ cells - the trial is placebo-controlled and double- ... blinded, so he doesnt know which - into his heart 10 times to deliver the cells." ...
Evidence for early recruitment of granulocyte precursors during high-dose methotrexate infusions in mice. Pinedo, H.M., Chabner ... CD34+ CD90+ cells and late hematopoietic reconstitution after autologous peripheral blood stem cell transplantation. Shimazaki ... Derivation of pluripotent stem cells from cultured human primordial germ cells. Shamblott, M.J., Axelman, J., Wang, S., Bugg, E ... Since Kupffer cells and T lymphocytes are derived from the same pluripotent stem cell, it was hypothesized that glycine would ...
Kim, T. H., Yang, K., Kim, M., Kim, H. S. & Kang, J. L., Jan 2021, In: Cell Death and Disease. 12, 1, 19.. Research output: ... An, M. & Kim, M., 2015, In: Anatomy and Cell Biology. 48, 4, p. 235-243 9 p.. Research output: Contribution to journal › ... Motion microscopy for label-free detection of circulating breast tumor cells. Kim, H., Ahn, Y. H., Kim, B. S., Park, S., Yoon, ... Apoptotic cells trigger the ABCA1/STAT6 pathway leading to PPAR-γ expression and activation in macrophages. Kim, M. J., Lee, Y ...
Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) ( ... Granulocyte Precursor Cells 38% 30 Scopus citations * Molecular Characterization and Clinical Relevance of Metabolic Expression ... The Cancer Genome Atlas Research Network, Jun 19 2018, In: Cell Reports. 23, 12, p. 3698 1 p.. Research output: Contribution to ... The Cancer Genome Atlas Research Network, Apr 9 2018, In: Cancer Cell. 33, 4, p. 721-735.e8. Research output: Contribution to ...
Granulocyte Precursor Cells 49% * Leucine Zippers 16% * Lipid Metabolism 12% * Transcriptional Activation 11% ...
Precursor Cell Lymphoblastic Leukemia-Lymphoma 75% * Cell Transplantation 27% * Disease-Free Survival 12% ... Erratum: Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire ... Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell ... Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) ( ...
Pure red blood cell (RBC) aplasia, in which there is complete disappearance of granulocyte tissue from the bone marrow; pure ... However, some drugs appear to have direct toxic effects on marrow stem cells or neutrophil precursors in the mitotic ... Its periodicity is about 21 days (range, 12-35 d). Granulocyte precursors disappear from the marrow before each neutrophil ... Disorders of the pluripotent myeloid stem cells and committed myeloid progenitor cells, which cause decreased neutrophil ...
It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally ... Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two ... Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation ... G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. ...
Venetoclax combination with standard regimens in follicular lymphoma, multiple myeloma and aggressive B cell neoplasms has ... Venetoclax is active in other lymphoid malignancies including several B cell non-Hodgkin lymphomas, acute lymphoblastic ... leukemia and multiple myeloma, with the highest intrinsic sensitivity observed in mantle cell lymphoma and Waldenstrom ... mimetics are a novel drug class of small molecule inhibitors of BCL2 family proteins which restore apoptosis in malignant cells ...
The production of certain immune cells (precursors of granulocytes macrophages). * The production of certain cytokines, which ... Melatonin is also a powerful antioxidant that helps protect body cells from damage caused by free radicals. ... promote the multiplication of killer cells NK (Natural Killer), leukocytes that destroy cells foreign to the body.. Melatonin ...
Granulocyte Colony-Stimulating Factor. *Granulocyte Precursor Cells. *Granulocyte-Macrophage Colony-Stimulating Factor ...
A malignancy in the myeloid lineage that includes precursor cells to red blood cells, platelets and white blood cells such as ... platelets and white blood cells such as granulocytes. For examples, acute myelogenous leukemia and chronic myelogenous leukemia ... And, malignancy in the myeloid lineage that includes precursor cells to red blood cells, ... The many distinct sorts of mature blood cells, like red blood cells for carrying oxygen, white blood cells for immune ...
Ferritin decreased the number of granulocyte-macrophages and red blood cell precursors in mice [5]. ... Ferritin is found in most tissues where it is located inside the cells. Within the cells, ferritin is mostly found in the ... It is the primary iron-storage protein within the cell, that stores iron in a soluble, non-toxic form, and transports it to ... It functions in cell detoxification, limiting the formation of reactive oxygen species, and mitigating their damaging effect on ...
... is a chronic myeloproliferative neoplasm characterized by the overproduction of red blood cells. ... It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally ... of early hematopoietic stem cells Hematopoietic stem cells Progenitor cells from which all blood cells derived. They are found ... such as renal cell carcinoma Renal cell carcinoma Renal cell carcinoma (RCC) is a tumor that arises from the lining of the ...
... activating T cells, reducing colitis, and treating intestinal inflammation were also reviewed in this paper. ... activating T cells, reducing colitis, and treating intestinal inflammation were also reviewed in this paper. ... of microorganisms on the surface of the intestinal mucosa and in the continuous renewal of intestinal epithelial cells. They ... of microorganisms on the surface of the intestinal mucosa and in the continuous renewal of intestinal epithelial cells. They ...
The SBDS gene may not be required for neutrophil maturation but may act to maintain survival of granulocyte precursor cells. ... Additionally, increased apoptosis of nontransformed cells through Fas stimulation leads to a growth advantage in mutated cells ... SBDS-deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growth. ... SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway. Haematologica. 2008 Mar. 93(3):363-71. [QxMD ...
... and granulocyte (ALDHhiSSChi) precursor cells in both groups were similar. At 6 mo, participants randomized to empagliflozin ... Precursor cell phenotypes were characterized by flow cytometry for cell-surface markers combined with high aldehyde ... The capacity to protect cells is evident both in vitro, as well as in mouse xenografts of those cells, shielding cells ... Following 16 h cell treatments with either H2O2 or etoposide, a significantly lower percentage of ALDH3A1/HCE-2 cells were ...
... induces the cancerous cells to differentiate from a granulocyte precursor into a mature myelocyte that can no longer divide.7 ... cell & molecular biology. cell adhesion. disease/medicine. genetics & genomics. oncogene. tumor. tumor suppression. ... Abnormal cell division is a hallmark of tumor cells. The mutated genes responsible for this proliferation are called cancer ... The heavy form of HA that occurs in the NMR prevents the transformation of normal cells into cancer cells; only after it has ...
... immature granulocytes). Immature granulocytes are precursors to neutrophils, the bodys first responders to an infection. A ... Routine laboratory parameters include WBCs (white blood cell counts), ANC (absolute neutrophil count), and IG ( ... We have also looked at various hematologic factors and other biomarkers, including immature granulocytes, ANC, WBC, ...
... is a myeloproliferative disorder characterized by increased proliferation of the granulocytic cell line without the loss of ... Consequently, the peripheral blood cell profile shows an increased number of granulocytes and their immature precursors, ... Blood film at 400X magnification demonstrates leukocytosis with the presence of precursor cells of the myeloid lineage. In ... Hypercellularity, with expansion of the myeloid cell line (eg, neutrophils, eosinophils, basophils) and its progenitor cells ...
It is an Acute Non-Lymphocytic type of malignanacy that involves myeloblast cells(precursor of monocytes and granulocytes). ... When there are multiple mutations in the locus that controls cell proliferation, cell maturation and cell death of precursor ... As the Cytotoxic T-cells and NK-cells lose their ability to kill cells infected with virus or other damaged cells, due to ... Acute - Fast progressing, takes weeks to few months, most of the cells are blast cells (immature cells), requires immediate ...
... normal T-cells and a population of maturing granulocytes and precursors. A distinct blast population is not seen. Peripheral ... Most of the red pulp is composed of erythroid islands, myeloid precursor cells and megakaryocytes. A subset of megakaryocytes ... The myeloid cells are left shifted, but blasts are not increased (CD34 and CD117 stains highlight about 5% of myeloid cells). ... Hairy cell leukemia is a differential diagnosis of splenic red pulp expansion. However, hairy cell leukemia causes red-pulp ...
Granulocyte-macrophage colony-stimulating factor derived from Recombinant human GM-CSF protein. Clone: BVD2-21C11. Gene ID: ... Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including ... B-cells, mast cells, macrophages, fibroblasts, and endothelial cells. In addition to supporting colony formation of granulocyte ... Granulocyte/macrophage - Colony-stimulating factor (GM-CSF) is a hematopoietic factor that is produced by activated T-cells, ...
Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including ... The ED50 as determined by a cell proliferation assay using human TF-1 cells is less than 0.1 ng/ml, corresponding to a specific ...
... calculated by the dose-dependant proliferation of murine NFS-60 indicator cells, is < 0.1 ng/ml, corresponding to a specific ... Granulocyte Colony-Stimulating Factor, Pluripoietin, Filgrastim, Lenograstim, CSF3, C17orf33, GCSF), ... and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. G-CSF ... Cell Biology Stable Cell Lines. DNA Transfection. Primary Cells. Stem Cells. Featured Cell Biology Products. DNA Transfection ...
... we studied the effect of MAA with and without hemin on energy metabolism of HL60 cells, a granulocyte precursor cell line. The ... Th1 cells, Th-GM cells, cytotoxic T (Tc) cells, monocytes, natural killer (NK) cells, and B cells in PBMC from MS patients ... activating T cells to recognize and kill cancer cells antigen-specifically. Many uninfected cancer or/and stromal cells can be ... activating and directing endogenous T cells to recognize and kill the tumor cells or/and stromal cells effectively (even if not ...
... then assayed for granulocyte-macrophage precursor cells by the technique of colony formation in agar. ... 11) Cells which have lost the feu function are resistant to the colicins B, I or V while ton B mutants are resistant to all 3 ... 2) Red cell fraction chemiluminescence was examined in quantum metric equipment with FEU-39A and FEU-140 radiation detectors ... 1) When FLU-specific B cells were cultured in the presence of FLU-POL, the addition of rTRF markedly increased the frequencies ...

No FAQ available that match "granulocyte precursor cells"